Showing results (1-10 of 326) with videos related to
Sort By:
Pageof 33
European Archives of Psychiatry and Clinical Neuroscience|June 16, 2001
Epidemiology of severe insomnia and its consequences in GermanyG Hajak, Drug Safety|December 28, 1999
A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experienceG HajakDeutsche Medizinische Wochenschrift (1946)|December 2, 2006
[Dual acting reuptake inhibitors in the treatment of depression and pain]G HajakFrontiers in Psychology|December 10, 2021
Risk Assessment of Electroconvulsive Therapy in Clinical Routine: A 3-Year Analysis of Life-Threatening Events in More Than 3,000 Treatment SessionsVivien L Hajak, Göran Hajak, Christoph Ziegelmayer, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 4, 2013
The efficacy of agomelatine in previously-treated depressed patientsSiegfried Kasper, Göran HajakFortschritte Der Neurologie-Psychiatrie|January 1, 1996
[Coincidence of anxiety and sleep disorders. Overview and case reports]G Hajak, B BandelowDer Nervenarzt|June 10, 2009
[Insomnias. II. Pharmacological and psychotherapeutic treatment options]Dieter Riemann, Göran HajakCNS Drugs|August 5, 2004
Experience with zolpidem 'as needed' in primary care settingsGöran Hajak, Peter GeislerDer Nervenarzt|June 18, 2009
[Insomnias: I. Aetiology, pathophysiology and diagnostics]D Riemann, G HajakPharmacoeconomics|December 9, 1995
Clinical management of patients with insomnia. The role of zopicloneG Hajak, A RodenbeckPageof 33